Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

Active, not recruiting

Conditions: Breast Cancer

First Posted Date: 2008-01-08

Last Posted Date: 2025-01-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7000

Registration Number: NCT00588029

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer, New York, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States

Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

Phase 2

Completed

Conditions: CNS Cancer
CNS BRAIN

Interventions: Drug: temozolomide followed by high dose busulfan and thiotepa

First Posted Date: 2008-01-08

Last Posted Date: 2023-10-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT00588523

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma

Completed

Conditions: Melanoma

First Posted Date: 2008-01-08

Last Posted Date: 2023-09-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 754

Registration Number: NCT00588198

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Recruiting

Conditions: Neuroblastoma

Interventions: Other: Tumor and Marrow Markers

First Posted Date: 2008-01-08

Last Posted Date: 2025-06-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2070

Registration Number: NCT00588068

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Phase 2

Completed

Conditions: Allogeneic Stem Cell Transplant
Leukemia
Non-Hodgkins
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Lymphoblastic Lymphoma
Myelodysplastic Syndrome

Interventions: Drug: cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant

First Posted Date: 2008-01-07

Last Posted Date: 2017-03-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 129

Registration Number: NCT00587054

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Phase 2

Completed

Conditions: Hormonal Cycling
Prostate
Cancer

Interventions: Drug: GnRH
Drug: Ketoconazole
Drug: Bicalutamide
Drug: Testosterone transdermal gel
Drug: Estrogen transdermal patch

First Posted Date: 2008-01-07

Last Posted Date: 2016-03-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 36

Registration Number: NCT00586898

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Peptide Profiles of Women Undergoing Breast Biopsy

Completed

Conditions: Breast Cancer

Interventions: Other: Blood draw

First Posted Date: 2008-01-07

Last Posted Date: 2013-12-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 571

Registration Number: NCT00587821

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Quality of Life in Lung Cancer Survivors

Completed

Conditions: Lung Cancer Survivors

Interventions: Behavioral: questionnaires or telephone interview

First Posted Date: 2008-01-07

Last Posted Date: 2020-01-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 193

Registration Number: NCT00586937

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: GnRh (Leuprolide)
Drug: Testosterone Gel
Drug: Docetaxel

First Posted Date: 2008-01-07

Last Posted Date: 2023-11-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 102

Registration Number: NCT00587431

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer

Not Applicable

Completed

Conditions: Ovarian Cancer

Interventions: Other: CA 125 and CT scan

First Posted Date: 2008-01-07

Last Posted Date: 2018-02-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 669

Registration Number: NCT00587093

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Md Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy